BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 15322172)

  • 21. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
    Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
    J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family-related protein(high), Foxp3-expressing CD25+ and CD25- regulatory T cells.
    Ono M; Shimizu J; Miyachi Y; Sakaguchi S
    J Immunol; 2006 Apr; 176(8):4748-56. PubMed ID: 16585568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells.
    Kanamaru F; Youngnak P; Hashiguchi M; Nishioka T; Takahashi T; Sakaguchi S; Ishikawa I; Azuma M
    J Immunol; 2004 Jun; 172(12):7306-14. PubMed ID: 15187106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin.
    Strauss L; Whiteside TL; Knights A; Bergmann C; Knuth A; Zippelius A
    J Immunol; 2007 Jan; 178(1):320-9. PubMed ID: 17182569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NFATc2 and NFATc3 transcription factors play a crucial role in suppression of CD4+ T lymphocytes by CD4+ CD25+ regulatory T cells.
    Bopp T; Palmetshofer A; Serfling E; Heib V; Schmitt S; Richter C; Klein M; Schild H; Schmitt E; Stassen M
    J Exp Med; 2005 Jan; 201(2):181-7. PubMed ID: 15657288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1 binding to CD4 on CD4+CD25+ regulatory T cells enhances their suppressive function and induces them to home to, and accumulate in, peripheral and mucosal lymphoid tissues: an additional mechanism of immunosuppression.
    Ji J; Cloyd MW
    Int Immunol; 2009 Mar; 21(3):283-94. PubMed ID: 19208751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crossover Subsets of CD4
    Li J; Ueno A; Iacucci M; Fort Gasia M; Jijon HB; Panaccione R; Kaplan GG; Beck PL; Luider J; Barkema HW; Qian J; Gui X; Ghosh S
    Dig Dis Sci; 2017 Sep; 62(9):2357-2368. PubMed ID: 28573508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells.
    Zheng SG; Wang JH; Stohl W; Kim KS; Gray JD; Horwitz DA
    J Immunol; 2006 Mar; 176(6):3321-9. PubMed ID: 16517699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4+CD25high regulatory cells in human peripheral blood.
    Baecher-Allan C; Brown JA; Freeman GJ; Hafler DA
    J Immunol; 2001 Aug; 167(3):1245-53. PubMed ID: 11466340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells.
    Yagi H; Nomura T; Nakamura K; Yamazaki S; Kitawaki T; Hori S; Maeda M; Onodera M; Uchiyama T; Fujii S; Sakaguchi S
    Int Immunol; 2004 Nov; 16(11):1643-56. PubMed ID: 15466453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal IFN-γ-producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease.
    Alfen JS; Larghi P; Facciotti F; Gagliani N; Bosotti R; Paroni M; Maglie S; Gruarin P; Vasco CM; Ranzani V; Frusteri C; Iseppon A; Moro M; Crosti MC; Gatti S; Pagani M; Caprioli F; Abrignani S; Flavell RA; Geginat J
    J Allergy Clin Immunol; 2018 Nov; 142(5):1537-1547.e8. PubMed ID: 29369775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA-4 expression.
    Birebent B; Lorho R; Lechartier H; de Guibert S; Alizadeh M; Vu N; Beauplet A; Robillard N; Semana G
    Eur J Immunol; 2004 Dec; 34(12):3485-96. PubMed ID: 15484187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.
    Fontenot JD; Gavin MA; Rudensky AY
    Nat Immunol; 2003 Apr; 4(4):330-6. PubMed ID: 12612578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted CTLA-4 engagement induces CD4+CD25+CTLA-4high T regulatory cells with target (allo)antigen specificity.
    Vasu C; Prabhakar BS; Holterman MJ
    J Immunol; 2004 Aug; 173(4):2866-76. PubMed ID: 15295006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity.
    Tsaknaridis L; Spencer L; Culbertson N; Hicks K; LaTocha D; Chou YK; Whitham RH; Bakke A; Jones RE; Offner H; Bourdette DN; Vandenbark AA
    J Neurosci Res; 2003 Oct; 74(2):296-308. PubMed ID: 14515359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGF-beta: how tolerant can it be?
    Wahl SM; Chen W
    Immunol Res; 2003; 28(3):167-79. PubMed ID: 14713712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased frequency of CD4(+)CD25(high) Treg cells inhibit BCG-specific induction of IFN-gamma by CD4(+) T cells from TB patients.
    Li L; Lao SH; Wu CY
    Tuberculosis (Edinb); 2007 Nov; 87(6):526-34. PubMed ID: 17851131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD3+CD4+LAP+Foxp3-Regulatory Cells of the Colonic Lamina Propria Limit Disease Extension in Ulcerative Colitis.
    Butera A; Sanchez M; Pronio A; Amendola A; De Nitto D; Di Carlo N; Lande R; Frasca L; Borrini F; Pica R; Boirivant M
    Front Immunol; 2018; 9():2511. PubMed ID: 30425718
    [No Abstract]   [Full Text] [Related]  

  • 40. Induction of antigen-specific regulatory T cells in the liver-draining celiac lymph node following oral antigen administration.
    Hultkrantz S; Ostman S; Telemo E
    Immunology; 2005 Nov; 116(3):362-72. PubMed ID: 16236126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.